Prospective evaluation in children of a new medical device intended to insure the correct administration of intrathecal antineoplastic agents
Corresponding Author
A. Lecomte PharmD
Pharmacy Clinical Oncology Unit (UPCO), Department of Pharmacy, CHU Hôtel-Dieu, Nantes, France
Pharmacy Clinical Oncology Unit (UPCO), Department of Pharmacy, CHU Hôtel-Dieu, BP 1005, 44093 Nantes Cédex 01, France.Search for more papers by this authorPatrick Thomaré PharmD, PhD
Pharmacy Clinical Oncology Unit (UPCO), Department of Pharmacy, CHU Hôtel-Dieu, Nantes, France
Search for more papers by this authorM. Courant PharmD
Pharmacy Clinical Oncology Unit (UPCO), Department of Pharmacy, CHU Hôtel-Dieu, Nantes, France
Search for more papers by this authorA. Suarez MD
Pediatric Oncology Unit, Department of Hematology, CHU Hôtel-Dieu, Nantes, France
Search for more papers by this authorF. Méchinaud MD
Pharmacy Clinical Oncology Unit (UPCO), Department of Pharmacy, CHU Hôtel-Dieu, Nantes, France
Search for more papers by this authorCorresponding Author
A. Lecomte PharmD
Pharmacy Clinical Oncology Unit (UPCO), Department of Pharmacy, CHU Hôtel-Dieu, Nantes, France
Pharmacy Clinical Oncology Unit (UPCO), Department of Pharmacy, CHU Hôtel-Dieu, BP 1005, 44093 Nantes Cédex 01, France.Search for more papers by this authorPatrick Thomaré PharmD, PhD
Pharmacy Clinical Oncology Unit (UPCO), Department of Pharmacy, CHU Hôtel-Dieu, Nantes, France
Search for more papers by this authorM. Courant PharmD
Pharmacy Clinical Oncology Unit (UPCO), Department of Pharmacy, CHU Hôtel-Dieu, Nantes, France
Search for more papers by this authorA. Suarez MD
Pediatric Oncology Unit, Department of Hematology, CHU Hôtel-Dieu, Nantes, France
Search for more papers by this authorF. Méchinaud MD
Pharmacy Clinical Oncology Unit (UPCO), Department of Pharmacy, CHU Hôtel-Dieu, Nantes, France
Search for more papers by this author
REFERENCES
- 1
Révész T,
Bierings M,
Rademaker C.
New technique for the intrathecal administration of chemotherapeutic agents.
Med Pediatr Oncol
2000;
34:
72–73.
10.1002/(SICI)1096-911X(200001)34:1<72::AID-MPO18>3.0.CO;2-# CAS PubMed Web of Science® Google Scholar
- 2
Trinkle R,
Wu JK.
Errors involving pediatric patients receiving chemotherapy: A litterature review.
Med Peditar Oncol
1996;
26:
344–351.
10.1002/(SICI)1096-911X(199605)26:5<344::AID-MPO7>3.0.CO;2-I CAS PubMed Web of Science® Google Scholar
- 3 Fernandez C, Esau R, Hamilton D, et al. Intrathecal vincristine: An analysis of reasons for recurrent fatal chemotherapeutic error with recommendations for prevention. J Pediatr Hematol Oncol 1998; 20: 587–590.
- 4 Fralle A. 2000. Protocol. Final version. AP-HP Group.
- 5 Madic A, De Maisonneuve A, Vincent A, et al. Antineoplastic cytotoxic agents centralized management: Contribution of a software integrated to the quality system. J Pharm Clin 2000; 19: 169–173.
- 6
Anderson R,
Egeler RM,
Coppes MJ.
Infallible measures needed to prevent errors in the administration of chemotherapeutic agents.
Med Peditar Oncol
1999;
32:
401–402.
10.1002/(SICI)1096-911X(199905)32:5<401::AID-MPO21>3.0.CO;2-P CAS PubMed Web of Science® Google Scholar
- 7 Yuen-Wah C, Vishnuvajjala BR, Flora KP. Stability of cytarabine, methotrexate sodium, and hydrocortisone sodium succinate admixtures. Am J Hosp Pharm 1984; 41: 1802–1806.
